|4/AMar 1, 4:56 PM ET

Onopchenko John 4/A

4/A · ENDOLOGIX INC /DE/ · Filed Mar 1, 2018

Insider Transaction Report

Form 4/AAmended
Period: 2017-10-30
Onopchenko John
Chief Operating Officer
Transactions
  • Award

    Common Shares

    2017-10-30+56,60456,604 total
  • Award

    Option to Purchase

    2017-10-30$5.30/sh+190,353$1,008,871190,353 total
    Exercise: $5.30From: 2018-10-30Exp: 2027-10-30Common Shares (190,353 underlying)
Footnotes (3)
  • [F1]Performance restricted stock unit award.
  • [F2]Twenty-five percent of the options shall vest upon one year of service and the remaining balance will vest in equal monthly installments thereafter.
  • [F3]On November 1, 2017, the reporting person filed a Form 4 which inadvertently reported that he acquired an option to purchase 187,464 shares of the issuer's common stock. In fact, as reported in this amendment, the reporting person acquired an option to purchase 190,353 shares of the issuer's common stock, as originally approved by the issuer's board of directors.

Documents

1 file
  • 4
    wf-form4a_151994134371578.xml

    FORM 4/A